These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 29474983)

  • 21. The RNA helicase DDX39B and its paralog DDX39A regulate androgen receptor splice variant AR-V7 generation.
    Nakata D; Nakao S; Nakayama K; Araki S; Nakayama Y; Aparicio S; Hara T; Nakanishi A
    Biochem Biophys Res Commun; 2017 Jan; 483(1):271-276. PubMed ID: 28025139
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development and Analytical Validation of a 6-Plex Reverse Transcription Droplet Digital PCR Assay for the Absolute Quantification of Prostate Cancer Biomarkers in Circulating Tumor Cells of Patients with Metastatic Castration-Resistant Prostate Cancer.
    Zavridou M; Smilkou S; Tserpeli V; Sfika A; Bournakis E; Strati A; Lianidou E
    Clin Chem; 2022 Oct; 68(10):1323-1335. PubMed ID: 36093578
    [TBL] [Abstract][Full Text] [Related]  

  • 23. AR-v7 liquid biopsy for treatment stratification in prostate cancer: how close are we?
    Fletcher C
    Curr Opin Urol; 2017 Sep; 27(5):500-509. PubMed ID: 28590268
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Urine-based liquid biopsy: non-invasive and sensitive AR-V7 detection in urinary EVs from patients with prostate cancer.
    Woo HK; Park J; Ku JY; Lee CH; Sunkara V; Ha HK; Cho YK
    Lab Chip; 2018 Dec; 19(1):87-97. PubMed ID: 30500003
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential regulation of metabolic pathways by androgen receptor (AR) and its constitutively active splice variant, AR-V7, in prostate cancer cells.
    Shafi AA; Putluri V; Arnold JM; Tsouko E; Maity S; Roberts JM; Coarfa C; Frigo DE; Putluri N; Sreekumar A; Weigel NL
    Oncotarget; 2015 Oct; 6(31):31997-2012. PubMed ID: 26378018
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Branched Chain RNA In Situ Hybridization for Androgen Receptor Splice Variant AR-V7 as a Prognostic Biomarker for Metastatic Castration-Sensitive Prostate Cancer.
    Saylor PJ; Lee RJ; Arora KS; Deshpande V; Hu R; Olivier K; Meneely E; Rivera MN; Ting DT; Wu CL; Miyamoto DT
    Clin Cancer Res; 2017 Jan; 23(2):363-369. PubMed ID: 27440270
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cell-Free DNA Variant Sequencing Using Plasma and AR-V7 Testing of Circulating Tumor Cells in Prostate Cancer Patients.
    Lieb V; Abdulrahman A; Weigelt K; Hauch S; Gombert M; Guzman J; Bellut L; Goebell PJ; Stöhr R; Hartmann A; Wullich B; Taubert H; Wach S
    Cells; 2021 Nov; 10(11):. PubMed ID: 34831445
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Growth Inhibition by Testosterone in an Androgen Receptor Splice Variant-Driven Prostate Cancer Model.
    Nakata D; Nakayama K; Masaki T; Tanaka A; Kusaka M; Watanabe T
    Prostate; 2016 Dec; 76(16):1536-1545. PubMed ID: 27473672
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CUDC-101, a Novel Inhibitor of Full-Length Androgen Receptor (flAR) and Androgen Receptor Variant 7 (AR-V7) Activity: Mechanism of Action and In Vivo Efficacy.
    Sun H; Mediwala SN; Szafran AT; Mancini MA; Marcelli M
    Horm Cancer; 2016 Jun; 7(3):196-210. PubMed ID: 26957440
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comprehensive Profiling of the Androgen Receptor in Liquid Biopsies from Castration-resistant Prostate Cancer Reveals Novel Intra-AR Structural Variation and Splice Variant Expression Patterns.
    De Laere B; van Dam PJ; Whitington T; Mayrhofer M; Diaz EH; Van den Eynden G; Vandebroek J; Del-Favero J; Van Laere S; Dirix L; Grönberg H; Lindberg J
    Eur Urol; 2017 Aug; 72(2):192-200. PubMed ID: 28104311
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Androgen receptor variant-7: an important predictive biomarker in castrate resistant prostate cancer.
    Sartor O; Dong Y
    Asian J Androl; 2015; 17(3):439-40. PubMed ID: 25532583
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Histone demethylase JMJD1A promotes alternative splicing of AR variant 7 (AR-V7) in prostate cancer cells.
    Fan L; Zhang F; Xu S; Cui X; Hussain A; Fazli L; Gleave M; Dong X; Qi J
    Proc Natl Acad Sci U S A; 2018 May; 115(20):E4584-E4593. PubMed ID: 29712835
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gene expression analysis of bone metastasis and circulating tumor cells from metastatic castrate-resistant prostate cancer patients.
    Cho WJ; Oliveira DS; Najy AJ; Mainetti LE; Aoun HD; Cher ML; Heath E; Kim HR; Bonfil RD
    J Transl Med; 2016 Mar; 14():72. PubMed ID: 26975354
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Detection of androgen receptor mutations in circulating tumor cells in castration-resistant prostate cancer.
    Jiang Y; Palma JF; Agus DB; Wang Y; Gross ME
    Clin Chem; 2010 Sep; 56(9):1492-5. PubMed ID: 20581083
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical Utility of CLIA-Grade AR-V7 Testing in Patients With Metastatic Castration-Resistant Prostate Cancer.
    Markowski MC; Silberstein JL; Eshleman JR; Eisenberger MA; Luo J; Antonarakis ES
    JCO Precis Oncol; 2017; 2017():. PubMed ID: 29170762
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CTC-mRNA (AR-V7) Analysis from Blood Samples-Impact of Blood Collection Tube and Storage Time.
    Luk AWS; Ma Y; Ding PN; Young FP; Chua W; Balakrishnar B; Dransfield DT; Souza P; Becker TM
    Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28498319
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Androgen receptor variant shows heterogeneous expression in prostate cancer according to differentiation stage.
    Gjyrezi A; Galletti G; Zhang J; Worroll D; Sigouros M; Kim S; Cooley V; Ballman KV; Ocean AJ; Shah MA; Scandura JM; Sboner A; Nanus DM; Beltran H; Tagawa S; Giannakakou P
    Commun Biol; 2021 Jun; 4(1):785. PubMed ID: 34168263
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic Value of Androgen Receptor Splice Variant 7 in the Treatment of Castration-resistant Prostate Cancer with Next generation Androgen Receptor Signal Inhibition: A Systematic Review and Meta-analysis.
    Li H; Wang Z; Tang K; Zhou H; Liu H; Yan L; Guan W; Chen K; Xu H; Ye Z
    Eur Urol Focus; 2018 Jul; 4(4):529-539. PubMed ID: 28753843
    [TBL] [Abstract][Full Text] [Related]  

  • 39. AR-V7 Protein in Circulating Tumor Cells-The Decider for Therapy?
    Montgomery RB; Plymate SR
    JAMA Oncol; 2016 Nov; 2(11):1450-1451. PubMed ID: 27261766
    [No Abstract]   [Full Text] [Related]  

  • 40. Circulating Tumor Cells Expressing the Prostate Specific Membrane Antigen (PSMA) Indicate Worse Outcome in Primary, Non-Metastatic Triple-Negative Breast Cancer.
    Kasimir-Bauer S; Keup C; Hoffmann O; Hauch S; Kimmig R; Bittner AK
    Front Oncol; 2020; 10():1658. PubMed ID: 33014830
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.